HEMANGIOBLASTOMA
Clinical trials for HEMANGIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEMANGIOBLASTOMA trials appear
Sign up with your email to follow new studies for HEMANGIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New scan could spot hidden brain tumors missed by standard MRI
Diagnosis Recruiting nowThis study is testing whether a special type of PET/MRI scan (using a radioactive tracer called 68Ga-DOTATATE) can better detect brain tumors, especially meningiomas, and tell the difference between tumor regrowth and changes from previous treatment. About 200 adults with certain…
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated May 17, 2026 00:28 UTC
-
Brain tumor study aims to sharpen diagnosis and treatment
Knowledge-focused Recruiting nowThis study looks at how the latest brain tumor classification system (from 2021) helps doctors better understand and treat different types of brain tumors. Researchers will collect data from 1,650 patients to see if the new system groups patients more accurately and to create tre…
Matched conditions: HEMANGIOBLASTOMA
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC